These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The p53 gene in breast cancer: prognostic value of complementary DNA sequencing versus immunohistochemistry. Sjögren S; Inganäs M; Norberg T; Lindgren A; Nordgren H; Holmberg L; Bergh J J Natl Cancer Inst; 1996 Feb; 88(3-4):173-82. PubMed ID: 8632491 [TBL] [Abstract][Full Text] [Related]
5. Enzymatic mutation detection (EMD) of novel mutations (R565X and R1523X) in the FBN1 gene of patients with Marfan syndrome using T4 endonuclease VII. Youil R; Toner TJ; Bull E; Bailey AL; Earl CD; Dietz HC; Montgomery RA Hum Mutat; 2000 Jul; 16(1):92-3. PubMed ID: 10874320 [TBL] [Abstract][Full Text] [Related]
6. Comparison between p53 protein measurements using the luminometric immunoassay and immunohistochemistry with detection of p53 gene mutations using cDNA sequencing in human breast tumors. Norberg T; Lennerstrand J; Inganäs M; Bergh J Int J Cancer; 1998 Aug; 79(4):376-83. PubMed ID: 9699530 [TBL] [Abstract][Full Text] [Related]
7. Rapid sequencing of the p53 gene with a new automated DNA sequencer. Bharaj BS; Angelopoulou K; Diamandis EP Clin Chem; 1998 Jul; 44(7):1397-403. PubMed ID: 9665415 [TBL] [Abstract][Full Text] [Related]
8. p53 abnormalities in primary prostate cancer: single-strand conformation polymorphism analysis of complementary DNA in comparison with genomic DNA. The Cooperative Prostate Network. Gumerlock PH; Chi SG; Shi XB; Voeller HJ; Jacobson JW; Gelmann EP; deVere White RW J Natl Cancer Inst; 1997 Jan; 89(1):66-71. PubMed ID: 8978408 [TBL] [Abstract][Full Text] [Related]
9. Expression of full-length p53 and its isoform Deltap53 in breast carcinomas in relation to mutation status and clinical parameters. Baumbusch LO; Myhre S; Langerød A; Bergamaschi A; Geisler SB; Lønning PE; Deppert W; Dornreiter I; Børresen-Dale AL Mol Cancer; 2006 Oct; 5():47. PubMed ID: 17054774 [TBL] [Abstract][Full Text] [Related]
10. Improving the detection of p53 mutations in breast cancer by use of the FASAY, a functional assay. Duddy PM; Hanby AM; Barnes DM; Camplejohn RS J Mol Diagn; 2000 Aug; 2(3):139-44. PubMed ID: 11229518 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of enzymatic mutation detectiontrade mark in hereditary nonpolyposis colorectal cancer. Otway R; Tetlow N; Hornby J; Kohonen-Corish M Hum Mutat; 2000; 16(1):61-7. PubMed ID: 10874307 [TBL] [Abstract][Full Text] [Related]
12. Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutations. Phillips KA; Nichol K; Ozcelik H; Knight J; Done SJ; Goodwin PJ; Andrulis IL J Natl Cancer Inst; 1999 Mar; 91(5):469-73. PubMed ID: 10070948 [TBL] [Abstract][Full Text] [Related]
13. Rat p53 gene mutations in primary Zymbal gland tumors induced by 2-amino-3-methylimidazo[4,5-f]quinoline, a food mutagen. Makino H; Ishizaka Y; Tsujimoto A; Nakamura T; Onda M; Sugimura T; Nagao M Proc Natl Acad Sci U S A; 1992 Jun; 89(11):4850-4. PubMed ID: 1594584 [TBL] [Abstract][Full Text] [Related]
14. Concordance between p53 protein overexpression and gene mutation in a large series of common human carcinomas. Soong R; Robbins PD; Dix BR; Grieu F; Lim B; Knowles S; Williams KE; Turbett GR; House AK; Iacopetta BJ Hum Pathol; 1996 Oct; 27(10):1050-5. PubMed ID: 8892589 [TBL] [Abstract][Full Text] [Related]
15. Somatic mutation analysis of p53 and ST7 tumor suppressor genes in gastric carcinoma by DHPLC. Lu C; Xu HM; Ren Q; Ao Y; Wang ZN; Ao X; Jiang L; Luo Y; Zhang X World J Gastroenterol; 2003 Dec; 9(12):2662-5. PubMed ID: 14669308 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of mutations to different structural and functional regions of the p53 gene in breast cancer. Powell B; Soong R; Iacopetta B; Seshadri R; Smith DR Clin Cancer Res; 2000 Feb; 6(2):443-51. PubMed ID: 10690522 [TBL] [Abstract][Full Text] [Related]
17. An endonuclease/ligase based mutation scanning method especially suited for analysis of neoplastic tissue. Huang J; Kirk B; Favis R; Soussi T; Paty P; Cao W; Barany F Oncogene; 2002 Mar; 21(12):1909-21. PubMed ID: 11896624 [TBL] [Abstract][Full Text] [Related]
19. p53 mutations are confined to the comedo type ductal carcinoma in situ of the breast. Immunohistochemical and sequencing data. O'Malley FP; Vnencak-Jones CL; Dupont WD; Parl F; Manning S; Page DL Lab Invest; 1994 Jul; 71(1):67-72. PubMed ID: 8041120 [TBL] [Abstract][Full Text] [Related]
20. [Comparison of nuclear accumulation of p53 protein with mutations in the p53 gene on the tissues of human breast cancer]. Fan P; Wu Z; Cha X; Wang X; Wang S Zhonghua Wai Ke Za Zhi; 1998 Nov; 36(11):655-7. PubMed ID: 11825490 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]